Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations.
about
Treatment Individualization in Colorectal CancerMolecular phenotypes of colorectal cancer and potential clinical applicationsPrimary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategiesFirst-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancerMolecular markers predictive of chemotherapy response in colorectal cancerEpidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair GenesAnti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories.Functional exploration of colorectal cancer genomes using Drosophila.Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology.PIK3CA mutant tumors depend on oxoglutarate dehydrogenase.Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer.
P2860
Q26776215-E8BFC6D2-2425-4366-9EB9-418B0371F050Q26785725-A2440426-5792-4356-9A77-C1C400E8369AQ27015224-3B6E5DE0-296C-4EA0-8F77-14777B5BB992Q34626967-D6CF3C4A-4E39-4EAA-9C83-4D4872DC2AA4Q35761956-DE380600-77F1-4E44-A1B1-E68ADB81AE19Q35885555-5334EC13-9929-41C7-9546-4870501F2458Q37243493-F99F6E6F-2FC6-4568-9FCB-CA9549CC69E8Q38219290-402A75D4-DABE-41EE-93BE-1E40FAF4195AQ39145987-06E7EBB4-6241-46E1-A6DA-EBFE551D902EQ39967039-C658EBFE-08D1-4467-9D0A-EDD53E62C6AEQ42580090-4A3F5821-F7B8-45C7-A530-444C3BFF38EFQ47107317-5667F869-6275-4DC8-9F7F-B0001C5271B1
P2860
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@ast
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@en
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@nl
type
label
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@ast
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@en
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@nl
prefLabel
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@ast
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@en
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@nl
P2093
P2860
P50
P1476
Target-based therapeutic match ...... l cancer and PIK3CA mutations.
@en
P2093
David S Hong
E Scott Kopetz
Gerald S Falchook
J Jack Lee
Jennifer J Wheler
Michael J Overman
Prasanth Ganesan
Rajyalakshmi Luthra
Robert A Wolff
Vanda M Stepanek
P2860
P304
P356
10.1158/1535-7163.MCT-13-0319-T
P577
2013-10-03T00:00:00Z